Hyperbaric oxygen (HBO) therapy is frequently used to treat peripheral wounds or decompression sickness. Evidence suggests that HBO therapy can provide neuroprotection and has an anti-inflammatory impact after neurological injury, including spinal cord injury (SCI). Our primary purpose was to conduct a genome-wide screening of mRNA expression changes in the injured spinal cord after HBO therapy. An mRNA gene array was used to evaluate samples taken from the contused region of the spinal cord following a lateralized mid-cervical contusion injury in adult female rats. HBO therapy consisted of daily, 1-h sessions (3.0 ATA, 100% O2) initiated on the day of SCI and continued for 10 days. Gene set enrichment analyses indicated that HBO upregulated genes in pathways associated with electron transport, mitochondrial function, and oxidative phosphorylation, and downregulated genes in pathways associated with inflammation (including cytokines and nuclear factor kappa B [NF-κB]) and apoptotic signaling. In a separate cohort, spinal cord histology was performed to verify whether the HBO treatment impacted neuronal cell counts or inflammatory markers. Compared with untreated rats, there were increased NeuN positive cells in the spinal cord of HBO-treated rats (p = 0.004). We conclude that HBO therapy, initiated shortly after SCI and continued for 10 days, can alter the molecular signature of the lesioned spinal cord in a manner consistent with a neuroprotective impact.
Get full access to this article
View all access options for this article.
References
1.
HarchP.G. (2015). Hyperbaric oxygen in chronic traumatic brain injury: oxygen, pressure, and gene therapy. Med. Gas Res. 5, 9.
2.
FigueroaX.A., and WrightJ.K. (2016). Hyperbaric oxygen: B-level evidence in mild traumatic brain injury clinical trials. Neurology, 87, 1400–1406.
3.
MozayeniB.R., DuncanW., ZantE., LoveT.L., BeckmanR.L., and StollerK.P. (2019). The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms. Med. Gas Res. 9, 1–12.
4.
PatelN.P., and HuangJ.H. (2017). Hyperbaric oxygen therapy of spinal cord injury. Med. Gas Res. 7, 133–143.
5.
HiltonB.J., MoulsonA.J., and TetzlaffW. (2017). Neuroprotection and secondary damage following spinal cord injury: concepts and methods. Neurosci. Lett. 652, 3–10.
6.
EmeryE., AldanaP., BungeM.B., PuckettW., SrinivasanA., KeaneR.W., BetheaJ., and LeviA.D. (1998). Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89, 911–920.
7.
CroweM.J., BresnahanJ.C., ShumanS.L., MastersJ.N., and BeattieM.S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73–76.
8.
BungeR.P., PuckettW.R., BecerraJ.L., MarcilloA., and QuencerR.M. (1993). Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59, 75–89.
9.
KellyD.L.Jr., LassiterK.R., CalogeroJ.A., and AlexanderE.Jr. (1970). Effects of local hypothermia and tissue oxygen studies in experimental paraplegia. J. Neurosurg. 33, 554–563.
10.
KellyD.L.Jr., LassiterK.R., VongsvivutA., and SmithJ.M. (1972). Effects of hyperbaric oxygenation and tissue oxygen studies in experimental paraplegia. J. Neurosurg. 36, 425–429.
11.
YeoJ.D., McKenzieB., HindwoodB., and KidmanA. (1976). Treatment of paraplegic sheep with hyperbaric oxygen. Med. J. Aust. 1, 538–540.
12.
YeoJ.D., StabbackS., and McKenzieB. (1977). A study of the effects of hyperbaric oxygen on the experimental spinal cord injury. Med. J. Aust. 2, 145–147.
13.
HuangH., XueL., ZhangX., WengQ., ChenH., GuJ., YeS., ChenX., ZhangW., and LiaoH. (2013). Hyperbaric oxygen therapy provides neuroprotection following spinal cord injury in a rat model. Int. J. Clin. Exp. Pathol. 6, 1337–1342.
14.
DayanK., KeserA., KonyaliogluS., ErturkM., AydinF., SengulG., and DagciT. (2012). The effect of hyperbaric oxygen on neuroregeneration following acute thoracic spinal cord injury. Life Sci. 90, 360–364.
15.
YingX., TuW., LiS., WuQ., ChenX., ZhouY., HuJ., YangG., and JiangS. (2019). Hyperbaric oxygen therapy reduces apoptosis and dendritic/synaptic degeneration via the BDNF/TrkB signaling pathways in SCI rats. Life Sci. 229, 187–199.
16.
LongY., LiangF., GaoC., LiZ., and YangJ. (2014). Hyperbaric oxygen therapy reduces apoptosis after spinal cord injury in rats. Int. J. Clin. Exp. Med. 7, 4073–4081.
17.
WangY., LiC., GaoC., LiZ., YangJ., LiuX., and LiangF. (2016). Effects of hyperbaric oxygen therapy on RAGE and MCP-1 expression in rats with spinal cord injury. Mol. Med. Rep. 14, 5619–5625.
18.
SunY., LiuD., SuP., LinF., and TangQ. (2016). Changes in autophagy in rats after spinal cord injury and the effect of hyperbaric oxygen on autophagy. Neurosci. Lett. 618, 139–145.
19.
WangY., ZhangS., LuoM., and LiY. (2014). Hyperbaric oxygen therapy improves local microenvironment after spinal cord injury. Neural Regen. Res. 9, 2182–2188.
20.
ZhouY., DongQ., PanZ., SongY., SuP., NiuY., SunY., and LiuD. (2019). Hyperbaric oxygen improves functional recovery of the injured spinal cord by inhibiting inflammation and glial scar formation. Am. J. Phys. Med. Rehabil. 98, 914–920.
21.
SubramanianA., TamayoP., MoothaV.K., MukherjeeS., EbertB.L., GilletteM.A., PaulovichA., PomeroyS.L., GolubT.R., LanderE.S., and MesirovJ.P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15, 545–15,550.
22.
ScheffS.W., RabchevskyA.G., FugacciaI., MainJ.A., and LumppJ.E. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma, 20, 179–193.
23.
IrizarryR.A., HobbsB., CollinF., Beazer-BarclayY.D., AntonellisK.J., ScherfU., and SpeedT.P. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249–264.
24.
GautierL., CopeL., BolstadB.M., and IrizarryR.A. (2004). affy––analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307–315.
25.
GentlemanR.C., CareyV.J., BatesD.M., BolstadB., DettlingM., DudoitS., EllisB., GautierL., GeY., GentryJ., HornikK., HothornT., HuberW., IacusS., IrizarryR., LeischF., LiC., MaechlerM., RossiniA.J., SawitzkiG., SmithC., SmythG., TierneyL., YangJ.Y., and ZhangJ. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80.
26.
DaiM., WangP., BoydA.D., KostovG., AtheyB., JonesE.G., BunneyW.E., MyersR.M., SpeedT.P., AkilH., WatsonS.J., and MengF. (2005). Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175.
27.
BrettschneiderJ., CollinF., BolstadB.M., and SpeedT.P. (2008). Quality assessment for short oligonucleotide microarray data. Technomet. 50, 241–264.
28.
BenjaminiY., and HochbergY. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300.
29.
NCBI Research Coordinators (2013). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 41, D8–D20.
30.
SchmittgenT.D., and LivakK.J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101–1108.
31.
LiberzonA., BirgerC., ThorvaldsdottirH., GhandiM., MesirovJ.P., and TamayoP. (2015). The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425.
32.
FalavignaA., TelesA.R., VelhoM.C., and KleberF.D. (2009). Effects of hyperbaric oxygen therapy after spinal cord injury: systematic review. Coluna/Columna, 8, 330–336.
33.
DingZ., TongW.C., LuX.X., and PengH.P. (2014). Hyperbaric oxygen therapy in acute ischemic stroke: a review. Interv. Neurol. 2, 201–211.
34.
CiarloneG.E., HinojoC.M., StavitzskiN.M., and DeanJ.B. (2019). CNS function and dysfunction during exposure to hyperbaric oxygen in operational and clinical settings. Redox Biol. 27, 101159.
35.
SimonA.J., and TorbatiD. (1982). Effects of hyperbaric oxygen on heart, brain, and lung functions in rat. Undersea Biomed. Res. 9, 263–275.
36.
TibblesP.M., and EdelsbergJ.S. (1996). Hyperbaric-oxygen therapy. N. Engl. J. Med. 334, 1642–1648.
37.
YildizS., AktasS., CimsitM., AyH., and TogrolE. (2004). Seizure incidence in 80,000 patient treatments with hyperbaric oxygen. Aviat. Space Environ. Med. 75, 992–994.
38.
HigginsA.C., PearlsteinR.D., MullenJ.B., and NasholdB.S.Jr. (1981). Effects of hyperbaric oxygen therapy on long-tract neuronal conduction in the acute phase of spinal cord injury. J. Neurosurg. 55, 501–510.
39.
MurakamiN., HorinouchiT., SakuraiM., ENjimaY., MatsukawaS., KatoM., and TabayashiK. (2001). Hyperbaric oxygen therapy given 30 minutes after spinal cord ischemia attenuates selective motor neuron death in rabbits. Crit. Care Med. 29, 814–818.
40.
HuangL., MehtaM.P., NandaA., and ZhangJ.H. (2003). The role of multiple hyperbaric oxygenation in expanding therapeutic windows after acute spinal cord injury in rats. J. Neurosurg. 99, 198–205.
41.
KahramanS., DuzB., KayaliH., KorkmazA., OterS., AydinA., and SayalA. (2007). Effects of methylprednisolone and hyperbaric oxygen on oxidative status after experimental spinal cord injury: a comparative study in rats. Neurochem. Res. 32, 1547–1551.
42.
WangL., LiW., KangZ., LiuY., DengX., TaoH., XuW., LiR., SunX., and ZhangJ.H. (2009). Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats. J. Neurotrauma, 26, 55–66.
43.
RockswoldS.B., RockswoldG.L., VargoJ.M., EricksonC.A., SuttonR.L., BergmanT.A., and BirosM.H. (2001). Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J. Neurosurg. 94, 403–411.
44.
DaveK.R., PradoR., BustoR., RavalA.P., BradleyW.G., TorbatiD., and Perez-PinzonM.A. (2003). Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience, 120, 113–120.
ShamsZ., KhalatbaryA.R., AhmadvandH., ZareZ., and KianK. (2017). Neuroprotective effects of hyperbaric oxygen (HBO) therapy on neuronal death induced by sciatic nerve transection in rat. BMC Neurol. 17, 220.
47.
DuncanI.D., BrowerA., KondoY., CurleeJ.F.Jr., and SchultzR.D. (2009). Extensive remyelination of the CNS leads to functional recovery. Proc. Natl. Acad. Sci. U. S. A. 106, 6832–6836.
48.
SaitoT., SaitoS., YamamotoH., and TsuchidaM. (2013). Neuroprotection following mild hypothermia after spinal cord ischemia in rats. J. Vasc. Surg. 57, 173–181.
49.
DoperalskiN.J., SandhuM.S., BavisR.W., ReierP.J., and FullerD.D. (2008). Ventilation and phrenic output following high cervical spinal hemisection in male vs. female rats. Respir. Physiol. Neurobiol. 162, 160–167.
50.
RaghavaN., DasB.C., and RayS.K. (2017). Neuroprotective effects of estrogen in CNS injuries: insights from animal models. Neurosci. Neuroecon. 6, 15–29.
51.
ZhaoY., ZhengY., XiaoZ., LiuJ., YangL., LiuF., and CaoD. (2020). Diffusion tensor imaging in the evaluation of the long-term efficacy of HBO2 therapy in rats after traumatic spinal cord injury. Undersea Hyperb. Med. 47, 435–443.
52.
SunL., ZhaoL., LiP., LiuX., LiangF., JiangY., KangN., GaoC., and YangJ. (2019). Effect of hyperbaric oxygen therapy on HMGB1/NF-kappaB expression and prognosis of acute spinal cord injury: a randomized clinical trial. Neurosci. Lett. 692, 47–52.
53.
HuangL., ZhangQ., FuC., LiangZ., XiongF., HeC., and WeiQ. (2021). Effects of hyperbaric oxygen therapy on patients with spinal cord injury: a systematic review and meta-analysis of randomized controlled trials. J. Back Musculoskelet. Rehabil. 34, 905–913.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
